Pharma Aids Limited (DSE:PHARMAID)
Bangladesh · Delayed Price · Currency is BDT 615.60
-5.40 (-0.87%)
At close: Jul 23, 2026
Pharma Aids Financials Overview
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Revenue Revenue Growth | 495.7 | 438.09 | 421.23 | 308.49 | 323.05 | 280.29 |
Revenue Growth | 18.93% | 4.00% | 36.55% | -4.50% | 15.25% | 3.98% |
Gross Profit Gross Profit Growth | 155.67 | 131.99 | 129.36 | 51.29 | 103.47 | 105.34 |
Operating Income Operating Income Growth | 104.09 | 83.41 | 84.36 | 10.66 | 54.02 | 66.33 |
Net Income Net Income Growth | 77.65 | 63.82 | 61.19 | -6.38 | 34.76 | 50.26 |
Earnings Per Share EPS Growth | 24.89 | 20.45 | 19.61 | -2.05 | 11.14 | 16.11 |
EPS Growth | 46.27% | 4.30% | - | - | -30.83% | -4.22% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Investments Cash & Investments Growth | 39.16 | 11.2 | 32.72 | 15.12 | 24.91 | 19.98 |
Total Debt Total Debt Growth | 17.26 | 27.3 | 18.16 | 11.47 | 0.99 | 0.3 |
Net Cash (Debt) Net Cash Growth | 21.89 | -16.1 | 14.56 | 3.64 | 23.92 | 19.67 |
Net Cash Growth | 10.72% | - | 299.66% | -84.77% | 21.59% | 118.67% |
Net Cash Per Share Net Cash Per Share Growth | 7.02 | -5.16 | 4.67 | 1.17 | 7.67 | 6.31 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 62.91 | 39.76 | 22.79 | 7.27 | 33.85 | 31.41 |
Capital Expenditures CapEx Growth | -56.17 | -57.13 | -0.18 | -2.21 | -4.7 | -10.28 |
Free Cash Flow Free Cash Flow Growth | 6.74 | -17.37 | 22.6 | 5.06 | 29.15 | 21.12 |
Free Cash Flow Growth | - | - | 346.82% | -82.64% | 37.97% | -40.81% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Gross Margin | 31.41% | 30.13% | 30.71% | 16.63% | 32.03% | 37.58% |
Operating Margin | 21.00% | 19.04% | 20.03% | 3.46% | 16.72% | 23.66% |
Pretax Margin | 20.53% | 18.79% | 20.08% | 3.34% | 16.57% | 23.32% |
Profit Margin | 15.66% | 14.57% | 14.53% | -2.07% | 10.76% | 17.93% |
FCF Margin | 1.36% | -3.97% | 5.37% | 1.64% | 9.02% | 7.54% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 27, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Dividend Per Share Dividend Per Share Growth | 3.000 | 3.000 | 2.500 | 1.000 | 5.000 | 5.000 |
Dividend Per Share Growth | 20.00% | 20.00% | 150.00% | -80.00% | 0% | 0% |
Dividend Yield | 0.49% | 0.56% | 0.38% | 0.13% | 0.62% | 1.29% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 27, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PE Ratio | 24.74 | 26.18 | 34.09 | - | 73.14 | 24.70 |
P/FCF Ratio | 285.10 | - | 92.27 | 487.65 | 87.25 | 58.77 |
PS Ratio | 3.87 | 3.81 | 4.95 | 8.00 | 7.87 | 4.43 |